Clinical Trials in Seattle

Showing 1881-1900 of 8,049 trials

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

NCT04454463

The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.

Liver Diseases

Johns Hopkins Bloomberg School of Public Health1,649 participantsStarted Nov 2020

La Jolla, California, United States • Los Angeles, California, United States • San Diego, California, United States +13 more locations

Active Not RecruitingNA< 1 mile

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

NCT05478304

This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.

Ischemic StrokeSystemic Embolism

AtriCure, Inc.6,573 participantsStarted Jan 2023

Huntsville, Alabama, United States • Scottsdale, Arizona, United States • Jonesboro, Arkansas, United States +140 more locations

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Find Trials by Condition in Seattle

Efficacy of Virtual Warrior Renew Therapy for Veterans Who Experienced Military Sexual Trauma

Individualizing Incentives for Alcohol in the Severely Mentally Ill

Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies

Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis

Expanded Access of Sotorasib